Allphase Pharma Consulting, LLC
A Professional Service Provider for the Pharma Industry
A new Guideline for the treatment of cUTI just arrived.[1] First, we are glad that this somewhat mundane topic receives the attention it deserves. UTIs are often downplayed as minor infections, but the cUTI variety should not be taken lightly. Many patients still are admitted with life-threatening infections, so prompt Continue reading NEW IDSA cUTI GUIDELINE
The WHO just released the latest statistics on what has turned into the largest ever outbreak of Ebola virus (EBOV) in Africa. The epidemic started in Guinea around December 2013. As of 7/27/2014, Guinea, Liberia, Nigeria, and Sierra Leone have reported a total of 1323 cases, with 729 fatalities [i]. Most Continue reading Ebola – Fact Sheet (Updated 10/3/2014)
Several antibiotic classes are associated with QTc prolongation: macrolides, quinolones, the antimalarials that share the quinine structure, and many azole antifungals. FDA warned about the proarrhythmic effects of azithromycin in 2013 [i] but it is a recent publication by Rao which brings the message home again with some very disquieting Continue reading QT Prolongation with Azithromycin and Levofloxacin